Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2023 Jul 14

PMID 37446943

Authors

Vidhya Rekha Umapathy

Prabhu Manickam Natarajan

Bhuminathan Swamikannu

Affiliations

Soon will be listed here.

Abstract

Early detection is crucial for the treatment and prognosis of oral cancer, a potentially lethal condition. Tumor markers are abnormal biological byproducts produced by malignant cells that may be found and analyzed in a variety of bodily fluids, including saliva. Early detection and appropriate treatment can increase cure rates to 80-90% and considerably improve quality of life by reducing the need for costly, incapacitating medicines. Salivary diagnostics has drawn the interest of many researchers and has been proven to be an effective tool for both medication monitoring and the diagnosis of several systemic diseases. Since researchers are now searching for biomarkers in saliva, an accessible bodily fluid, for noninvasive diagnosis of oral cancer, measuring tumor markers in saliva is an interesting alternative to blood testing for early identification, post-treatment monitoring, and monitoring high-risk lesions. New molecular markers for oral cancer detection, treatment, and prognosis have been found as a result of developments in the fields of molecular biology and salivary proteomics. The numerous salivary tumor biomarkers and how they relate to oral cancer and pre-cancer are covered in this article. We are optimistic that salivary protein biomarkers may one day be discovered for the clinical detection of oral cancer because of the rapid advancement of proteomic technology.

Citing Articles

The Crucial Role of Smoking Cessation in Preventing Oral Cancer.

Natarajan P, Swamikannu B, Rahe R, Kamaraj B, Kamaraj L, Ramachandran V J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4245-S4247.

PMID: 40061748 PMC: 11888749. DOI: 10.4103/jpbs.jpbs_1306_24.

Mass Spectrometry-Based Proteomics in Clinical Diagnosis of Amyloidosis and Multiple Myeloma: A Review (2012-2024).

Kratka K, Sistik P, Olivkova I, Kusnierova P, Svagera Z, Stejskal D J Mass Spectrom. 2025; 60(3):e5116.

PMID: 39967472 PMC: 11836596. DOI: 10.1002/jms.5116.

The Role of Oral Biomarkers in the Assessment of Noncommunicable Diseases.

Saenz-Ravello G, Hernandez M, Baeza M, Hernandez-Rios P Diagnostics (Basel). 2025; 15(1.

PMID: 39795606 PMC: 11719684. DOI: 10.3390/diagnostics15010078.

Comparisons of Whole Saliva and Cell Free Saliva by DIA-Based Proteome Profiling.

Jiao L, Dong H, Qin Y, Zhu J, Wu P, Liu J Proteomics Clin Appl. 2024; 19(1):e202400031.

PMID: 39670294 PMC: 11726274. DOI: 10.1002/prca.202400031.

Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population.

Ghalwash D, Ammar A, Abou-Bakr A, Diab A, El-Gawish A Future Sci OA. 2024; 11(1):2432222.

PMID: 39641414 PMC: 11633404. DOI: 10.1080/20565623.2024.2432222.

References

Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I . Salivary analysis of oral cancer biomarkers. Br J Cancer. 2009; 101(7):1194-8. PMC: 2768098. DOI: 10.1038/sj.bjc.6605290. View

Ambatipudi K, Lu B, Hagen F, Melvin J, Yates J . Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J Proteome Res. 2009; 8(11):5093-102. PMC: 2834885. DOI: 10.1021/pr900478h. View

Oppenheim F, Salih E, Siqueira W, Zhang W, Helmerhorst E . Salivary proteome and its genetic polymorphisms. Ann N Y Acad Sci. 2007; 1098:22-50. DOI: 10.1196/annals.1384.030. View

Vitorino R, de Morais Guedes S, Ferreira R, Lobo M, Duarte J, Ferrer-Correia A . Two-dimensional electrophoresis study of in vitro pellicle formation and dental caries susceptibility. Eur J Oral Sci. 2006; 114(2):147-53. DOI: 10.1111/j.1600-0722.2006.00328.x. View

Gorugantula L, Rees T, Plemons J, Chen H, Cheng Y . Salivary basic fibroblast growth factor in patients with oral squamous cell carcinoma or oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114(2):215-22. PMC: 3393106. DOI: 10.1016/j.oooo.2012.03.013. View

Grassl N, Kulak N, Pichler G, Geyer P, Jung J, Schubert S . Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med. 2016; 8(1):44. PMC: 4841045. DOI: 10.1186/s13073-016-0293-0. View

Helmerhorst E, Oppenheim F . Saliva: a dynamic proteome. J Dent Res. 2007; 86(8):680-93. DOI: 10.1177/154405910708600802. View

Tabak L . A revolution in biomedical assessment: the development of salivary diagnostics. J Dent Educ. 2002; 65(12):1335-9. View

Matta A, Ralhan R, Desouza L, Siu K . Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery. Mass Spectrom Rev. 2010; 29(6):945-61. DOI: 10.1002/mas.20296. View

10.

Lippman S, Sudbo J, Hong W . Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005; 23(2):346-56. DOI: 10.1200/JCO.2005.09.128. View

11.

Rosas S, Koch W, da Costa Carvalho M, Wu L, Califano J, Westra W . Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001; 61(3):939-42. View

12.

Granger D, Kivlighan K, Fortunato C, Harmon A, Hibel L, Schwartz E . Integration of salivary biomarkers into developmental and behaviorally-oriented research: problems and solutions for collecting specimens. Physiol Behav. 2007; 92(4):583-90. DOI: 10.1016/j.physbeh.2007.05.004. View

13.

Markopoulos A, Michailidou E, Tzimagiorgis G . Salivary markers for oral cancer detection. Open Dent J. 2011; 4:172-8. PMC: 3111739. DOI: 10.2174/1874210601004010172. View

14.

Wu C, Chu H, Hsu C, Chang K, Liu H . Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma. Proteomics. 2015; 15(19):3394-404. DOI: 10.1002/pmic.201500157. View

15.

Messana I, Cabras T, Iavarone F, Manconi B, Huang L, Martelli C . Chrono-proteomics of human saliva: variations of the salivary proteome during human development. J Proteome Res. 2015; 14(4):1666-77. DOI: 10.1021/pr501270x. View

16.

De Jong E, Van Riper S, Koopmeiners J, Carlis J, Griffin T . Sample collection and handling considerations for peptidomic studies in whole saliva; implications for biomarker discovery. Clin Chim Acta. 2011; 412(23-24):2284-8. PMC: 3196990. DOI: 10.1016/j.cca.2011.08.023. View

17.

Franzmann E, Reategui E, Pedroso F, Pernas F, Karakullukcu B, Carraway K . Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(7):1348-55. DOI: 10.1158/1055-9965.EPI-06-0011. View

18.

Righini C, De Fraipont F, Timsit J, Faure C, Brambilla E, Reyt E . Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res. 2007; 13(4):1179-85. DOI: 10.1158/1078-0432.CCR-06-2027. View

19.

Liggett W, Barker P, John Semmes O, Cazares L . Measurement reproducibility in the early stages of biomarker development. Dis Markers. 2005; 20(6):295-307. PMC: 3839328. DOI: 10.1155/2004/726517. View

20.

Messana I, Cabras T, Iavarone F, Vincenzoni F, Urbani A, Castagnola M . Unraveling the different proteomic platforms. J Sep Sci. 2012; 36(1):128-39. DOI: 10.1002/jssc.201200830. View